Secondary Hypertrophic Osteoarthropathy
Symmetrical osteitis of the four limbs, chiefly localized to the phalanges and the terminal epiphyses of the long bones of the forearm and leg, sometimes extending to the proximal ends of the limbs and the flat bones, and accompanied by dorsal kyphosis and joint involvement. It is often secondary to chronic conditions of the lungs and heart. (Dorland, 27th ed)
Also Known As:
Osteoarthropathy, Secondary Hypertrophic; Hypertrophic Osteoarthropathy, Secondary; Clubbed Finger; Disease, Marie-Bamberger; Finger, Clubbed; Fingers, Clubbed; Hypertrophic Osteoarthropathies, Secondary; Marie Bamberger Disease; Osteoarthropathies, Secondary Hypertrophic; Secondary Hypertrophic Osteoarthropathies; Clubbed Fingers; Marie-Bamberger Disease
Networked: 12
relevant articles (1 outcomes,
0 trials/studies)
for this Disease,
Comments
Relationship Network
Disease Context: Research Results
Related Diseases
| 1. | Arthralgia (Joint Pain)
|
| 2. | Infection
|
| 3. | Liver Diseases (Liver Disease)
|
| 4. | Fistula
|
| 5. | Dyspnea (Shortness of Breath)
|
Experts
| 1. | Hambye, Anne-Sophie: 1 article (06/2008) |
| 2. | Castaigne, Catherine A: 1 article (06/2008) |
| 3. | Rodriguez-Valverde, Vicente: 1 article (05/2006) |
| 4. | Pina, Trinitario: 1 article (05/2006) |
| 5. | Martínez-Taboada, Victor Manuel: 1 article (05/2006) |
| 6. | Blanco, Ricardo: 1 article (05/2006) |
| 7. | Alonso-Bartolomé, Pilar: 1 article (05/2006) |
| 8. | Yagi, Hiroshi: 1 article (01/2004) |
| 9. | Ueda, Mikiko: 1 article (01/2004) |
| 10. | Tombak, Alexander: 1 article (01/2004) |
Drugs and Biologics
Drugs and Important Biological Agents (IBA) related to Secondary Hypertrophic Osteoarthropathy:Therapies and Procedures
TREATMENT OPTIONS
for Secondary Hypertrophic Osteoarthropathy,
Ranking and Evidence
for Secondary Hypertrophic Osteoarthropathy,
Ranking and Evidence
*WARNING* This specific disease subtype has a relatively small
number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a
more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.
CureHunter Patient-Physician Summary Reports collect in one document all the
medications ever reported in the US National Library of Medicine—1949 to the present—to
be effective against your target disease.
Analytic charts allow you and your physicians to see at a glance the
treatment options—including new, promising, off-label and experimental.
- Free Updates for 1 Year
- All 1 Outcomes
- Top 200 Key Drugs and Biologics
- Top 50 Key Therapies and Procedures
- Detailed History Charts
- Full Research Evidence References
- Sample PDF Report on Psoriasis >>
| Price: | $8.50 USD
& Delivery via
PDF download
updates for 1 year |
Research Interface PRO
- Two-clicks from Disease to Drug to Evidence: Drill down to full abstract
- Enable Experts: Quickly identify key researchers and their publications
- Enable FDA Link Generic: Two-clicks to FDA Products/Patents/Generics
- Enable Export: All outcome statements and scores exportable to Excel/TSV for automated meta-analysis
- Research Network: Explore drug and disease relationships visually
- Enable Mobile Interface: Access from your cellphone, iPhone or PDA
| Price: | $45.00 USD
access via web interface 1 year subscription |